关注
Takashi Tsukamoto
Takashi Tsukamoto
在 jhmi.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells
A Le, AN Lane, M Hamaker, S Bose, A Gouw, J Barbi, T Tsukamoto, ...
Cell metabolism 15 (1), 110-121, 2012
11922012
The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type
MO Yuneva, TWM Fan, TD Allen, RM Higashi, DV Ferraris, T Tsukamoto, ...
Cell metabolism 15 (2), 157-170, 2012
6962012
Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1
MJ Seltzer, BD Bennett, AD Joshi, P Gao, AG Thomas, DV Ferraris, ...
Cancer research 70 (22), 8981-8987, 2010
5922010
Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1, 2, 4-thiadiazol-2-yl) ethyl sulfide (BPTES)
MM Robinson, SJ Mcbryant, T Tsukamoto, C Rojas, DV Ferraris, ...
Biochemical Journal 406 (3), 407-414, 2007
3842007
Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer
L Yang, T Moss, LS Mangala, J Marini, H Zhao, S Wahlig, G Armaiz‐Pena, ...
Molecular systems biology 10 (5), 728, 2014
3582014
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer
JR Mesters, C Barinka, W Li, T Tsukamoto, P Majer, BS Slusher, ...
The EMBO journal 25 (6), 1375-1384, 2006
3412006
Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1, 2, 4-thiadiazol-2-yl) ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors
K Shukla, DV Ferraris, AG Thomas, M Stathis, B Duvall, G Delahanty, J Alt, ...
Journal of medicinal chemistry 55 (23), 10551-10563, 2012
2352012
Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer
A Elgogary, Q Xu, B Poore, J Alt, SC Zimmermann, L Zhao, J Fu, B Chen, ...
Proceedings of the National Academy of Sciences 113 (36), E5328-E5336, 2016
2262016
Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations
A Emadi, SA Jun, T Tsukamoto, AT Fathi, MD Minden, CV Dang
Experimental hematology 42 (4), 247-251, 2014
1832014
Molecular mechanisms of 5-HT3 and NK1 receptor antagonists in prevention of emesis
C Rojas, M Raje, T Tsukamoto, BS Slusher
European journal of pharmacology 722, 26-37, 2014
1782014
Synthesis and Biological Evaluation of d-Amino Acid Oxidase Inhibitors
D Ferraris, B Duvall, YS Ko, AG Thomas, C Rojas, P Majer, K Hashimoto, ...
Journal of medicinal chemistry 51 (12), 3357-3359, 2008
1632008
Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor
P Majer, PF Jackson, G Delahanty, BS Grella, YS Ko, W Li, Q Liu, ...
Journal of medicinal chemistry 46 (10), 1989-1996, 2003
1582003
Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine
K Hashimoto, Y Fujita, M Horio, S Kunitachi, M Iyo, D Ferraris, ...
Biological psychiatry 65 (12), 1103-1106, 2009
1502009
Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models
GD Ghadge, BS Slusher, A Bodner, MD Canto, K Wozniak, AG Thomas, ...
Proceedings of the National Academy of Sciences 100 (16), 9554-9559, 2003
1462003
High-affinity near-infrared fluorescent small-molecule contrast agents for in vivo imaging of prostate-specific membrane antigen
V Humblet, R Lapidus, LR Williams, T Tsukamoto, C Rojas, P Majer, B Hin, ...
Molecular imaging 4 (4), 7290.2005. 05163, 2005
1432005
Arginine deprivation inhibits the Warburg effect and upregulates glutamine anaplerosis and serine biosynthesis in ASS1-deficient cancers
JC Kremer, BC Prudner, SES Lange, GR Bean, MB Schultze, ...
Cell reports 18 (4), 991-1004, 2017
1382017
Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II
C Bařinka, M Rovenská, P Mlcochová, K Hlouchová, A Plechanovová, ...
Journal of medicinal chemistry 50 (14), 3267-3273, 2007
1282007
Progress in the discovery and development of glutamate carboxypeptidase II inhibitors
T Tsukamoto, KM Wozniak, BS Slusher
Drug discovery today 12 (17-18), 767-776, 2007
1232007
Arginine deiminase resistance in melanoma cells is associated with metabolic reprogramming, glucose dependence, and glutamine addiction
Y Long, WB Tsai, M Wangpaichitr, T Tsukamoto, N Savaraj, LG Feun, ...
Molecular cancer therapeutics 12 (11), 2581-2590, 2013
1222013
Design and pharmacological activity of phosphinic acid based NAALADase inhibitors
PF Jackson, KL Tays, KM Maclin, YS Ko, W Li, D Vitharana, T Tsukamoto, ...
Journal of medicinal chemistry 44 (24), 4170-4175, 2001
1212001
系统目前无法执行此操作,请稍后再试。
文章 1–20